Inhibitory effect of bovine lactoferrin on human parainfluenza virus type 2 infection

Journal of Health Science

Volumn 56, Issue 5, 2010, Pages 613-617

  Yamamoto, Hidetaka ^a   Ura, Yukari ^a   Tanemura, Miho ^a   Koyama, Aoi ^a   Takano, Sayaka ^a   Uematsu, Jun ^a   Kawano, Mitsuo ^b   Tsurudome, Masato ^b   O'Brien, Myles ^c   Komada, Hiroshi ^a  

^a SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MIE PREFECTURAL COLLEGE OF NURSING   (Japan)

Author keywords

Inhibition; Lactoferrin; Parainfluenza virus type 2

Indexed keywords

GREEN FLUORESCENT PROTEIN; LACTOFERRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL FUSION; CELL STRUCTURE; CONTROLLED STUDY; HEMADSORPTION; HUMAN; IMMUNOFLUORESCENCE; NONHUMAN; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS INFECTION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA SYNTHESIS; VIROGENESIS; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TITRATION;

BOVINAE; HUMAN PARAINFLUENZA VIRUS 2;

EID: 78049281435     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.56.613     Document Type: Article

References (24)

1. Lamb, R. A. and Parks, G. P. (2007) Paramyxoviridae: The viruses and their replication. In Fields Virology (Kniep, D. M. and Howley, P. M., Eds.), Lippincott Williams and Wilkins, pp.1449-1496.
2. Yuasa, T., Bando, H., Kawano, M., Tsurudome, M., Nishio, M., Kondo, K., Komada, H. and Ito, Y. (1990) Sequence analysis of the 3′ gemome end and NP gene of human parainfluenza type 2 virus: sequence variation of the gene-starting signal and the conserved 3′ end. Virology, 179, 777-784.
3. Ohgimoto, S., Bando, H., Kawano, M., Okamoto, K., Kondo, K., Tsurudome, M., Nishio, M. and Ito, Y. (1990) Sequence analysis of P gene of human parainfluenza type 2 virus; P and cystein-rich proteins are translated by two mRNAs that differ by two non-templated G residues. Virology, 177, 116-123.
4. Kawano, M., Bando, H., Ohgimoto, S., Okamoto, K., Kondo, K., Tsurudome, M., Nishio, M. and Ito, Y. (1990) Complete nucleotide sequence of the matrix gene of human parainfluenza type 2 virus and expression of the M protein in bacteria. Virology, 179, 857-861.
5. Kawano, M., Bando, H., Ohgimoto, S., Kondo, K., Tsurudome, M., Nishio, M. and Ito, Y. (1990) Sequence of the fusion protein gene of human parainfluenza type 2 virus and its 3′ intergenic region: lack of small hydrophobic (SH) gene. Virology, 178, 289-292.
6. Kawano, M., Bando, H., Yuasa, T., Kondo, K., Tsurudome, M., Komada, H., Nishio, M. and Ito, Y. (1990) Sequence determination of thehemagglutinin-neuraminidase (HN) gene of human parainfluenza type 2 virus and the construction of a phylogenetic tree for HN proteins of all the paramyxoviruses that are infectious to humans. Virology, 174, 308-313.
7. Kawano, M., Okamoto, K., Bando, H., Kondo, K., Tsurudome, M., Komada, H., Nishio, M. and Ito, Y. (1991) Characterizations of the human parainfluenza type 2 virus gene encoding the L protein and the intergenic sequences. Nucleic Acids Res., 19, 2739-2746.
8. Tsurudome, M., Nishio, M., Komada, H., Bando, H. and Ito, Y. (1989) Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramxoviruses revealed by monoclonal antibodies. Virology, 171, 38-48.
9. Kawano, M., Kaito, M., Kozuka, Y., Komada, H., Noda, N., Nanba, K., Tsurudome, M., Ito, M., Nishio, M. and Ito, Y. (2001) Recovery of infectious human parainfluenza type 2 virus from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain. Virology, 284, 99-112.
10. Ammendolia, M. G., Marchetti, M. and Superti, F. (2007) Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in green monkey kidney cells. Antiviral Res., 76, 252-262.
11. Harmsen, M. C., Swart, P. J., de Bethune, M. P., Pauwels, R., De Clercq, E., The, T. H. and Meijer, D. K. E. (1995) Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J. Infect. Dis., 172, 380-388.
12. Hara, K., Ikeda, M, Saito, S., Matsumoto, S., Numata, K., Kato, N., Tanaka, K. and Sekihara, H. (2002) Lactoferrin inhibits hepatitis B virus infection in cultured human hehatocytes. Hepatol. Res., 24, 228-235.
13. Ikeda, M., Sugiyama, K., Tanaka, T., Tanaka, K., Sekihara, H., Shimotono, K. and Kato, N. (1998) Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochem. Biophys. Res. Commun., 245, 549-553.
14. Sano, H., Nagai, K., Tsutsumi, H. and Kuroki, Y. (2003) Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection. Eur. J. Immunol., 33, 2894-2902.
15. Superti, F., Ammendolia, M. G., Valenti, P. and Seganti, L. (1997) Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Med. Microbiol. Immunol. (Berl.), 186, 83-91.
16. Marchetti, M., Superti, F., Ammendolia, M. G., Rossi, P., Valenti, P. and Seganti, L. (1999) Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin. Med. Microbiol. Immunol. (Berl.), 187, 199-204.
17. Tinari, A., Pietrantoni, A., Ammendolia, M. G., Valenti, P. and Superti, F. (2005) Inhibitory activity of bovine lactoferrin against echovirus induced programmed cell death in vitro. Int. J. Antimicrob. Agents, 25, 433-438.
18. Valenti, P. and Antonini, G. (2005) Lactoferrin: an important host defense against microbial and viral attack. Cell. Mol. Life Sci., 62, 2576-2587.
19. Jenssen, H. (2005) Anti herpes simplex virus activity of lactoferrin/lactoferricin-an example of antiviral activity of antimicrobial protein/peptide. Cell. Mol. Life Sci., 62, 3002-3013.
20. Ji, Z. S. and Mahley, R. W. (1994) Lactoferrin binding to heparan sulfate proteoglycans and LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSGP. Arterioscler. Thromb., 14, 2025-2031.
21. Valimaa, H., Tenovuo, J., Waris, M. and Hukkanen, V. (2009) Human lactoferrin but not lysozyme neutralize HSV-1 and inhibits HSV-1 replication and cell-to-cell spread. Virol. J., 6, 53-59.
22. Taoda, N., Shinji, E., Nishi, K., Nishioka, S., Yonezawa, Y., Uematsu, J., Hattori, E., Yamamoto, H., Kawano, M., Tsurudome, M., O'Brien, M., Yamashita, T. and Komada, H. (2008) Fucoidan inhibits parainfluenza virus type 2 infection to LLCMK2 cells. Biomed. Res., 29, 331-334.
23. Dechecchi, M. C., Melotti, P., Bonizzato, A., Santacatterina, M., Chilosi, M. and Cabrini, G. (2001) Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus type 2 and 5. J. Virol., 75, 8772-8780.
24. Giroglou, T., Florin, L., Schafer, F., Streeck, R. E. and Sapp, M. (2001) Human papillomavirus infection requires cell surface heparan sulfate. J. Virol., 75, 1565-1570.